WallStreetZenWallStreetZen

NASDAQ: PRAX
Praxis Precision Medicines Inc Stock Ownership - Who owns Praxis Precision Medicines?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Praxis Precision Medicines Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Marcio SouzaChief Executive Officer2025-02-12401$85.40
$34.25kSell
Lauren MastrocolaPrincipal Accounting Officer2025-02-1240$85.40
$3.42kSell
Alex NemiroffGeneral Counsel and Secretary2025-02-1251$85.40
$4.36kSell
Lauren MastrocolaPrincipal Accounting Officer2025-01-12390$63.15
$24.63kSell
Timothy Edwin KellyChief Financial Officer2025-01-12676$63.15
$42.69kSell
Alex NemiroffGeneral Counsel and Secretary2025-01-12579$63.15
$36.56kSell
Timothy Edwin KellyChief Financial Officer2025-01-07139$77.52
$10.78kSell
Lauren MastrocolaPrincipal Accounting Officer2025-01-0735$77.52
$2.71kSell
Marcio SouzaChief Executive Officer2025-01-07434$77.52
$33.64kSell
Alex NemiroffGeneral Counsel and Secretary2025-01-0789$77.52
$6.90kSell

1 of 2

PRAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PRAX insiders and whales buy or sell their stock.

PRAX Shareholders

What type of owners hold Praxis Precision Medicines Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bsof Parallel Master Fund LP24.27%4,894,109$165.37MInsider
Stefan Vitorovic14.58%2,939,329$99.32MInsider
Holdings A. Novo12.11%2,442,080$82.52MInsider
Cormorant Asset Management LP8.40%1,693,219$57.21MInstitution
Blackrock Inc7.25%1,462,445$49.42MInstitution
Perceptive Advisors LLC6.59%1,329,735$44.93MInstitution
Price T Rowe Associates Inc5.99%1,208,522$40.84MInstitution
Morgan Stanley5.77%1,163,526$39.32MInstitution
Vanguard Group Inc5.28%1,063,639$35.94MInstitution
Capital Research Global Investors4.93%993,569$33.57MInstitution

1 of 3

PRAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PRAX64.37%35.63%Net SellingNet Selling
QURE76.94%12.75%Net SellingNet Selling
CVAC3.50%0.00%
DAWN59.43%40.57%Net SellingNet Selling
IMNM61.31%7.69%Net BuyingNet Buying
View Top Biotech Stocks

Praxis Precision Medicines Stock Ownership FAQ

Who owns Praxis Precision Medicines?

Praxis Precision Medicines (NASDAQ: PRAX) is owned by 107.72% institutional shareholders, 59.62% Praxis Precision Medicines insiders, and 0.00% retail investors. Bsof Parallel Master Fund LP is the largest individual Praxis Precision Medicines shareholder, owning 4.89M shares representing 24.27% of the company. Bsof Parallel Master Fund LP's Praxis Precision Medicines shares are currently valued at $172.96M.

If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.